J&J INNOVATIVE MEDICINE
J&J INNOVATIVE MEDICINE has 1 FDA recall, 0 inspections, 0 510(k) clearances and 0 compliance actions on record.
- Latest recall
- D-0016-2027 · Class II · Sep 23, 2026
Reviewing J&J INNOVATIVE MEDICINE as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.
Or get J&J INNOVATIVE MEDICINE's full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site, in Claude, Cursor or ChatGPT.
Summary
- Recalls
- 1
- 510(k) Clearances
- 0
- Inspections
- 0
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0016-2027 | Class II | IMAAVY (nipocalimab-aahu) Injection, 300 mg /1.62 mL (185 mg/mL) per single-dose vial, For… | Sep 23, 2026 |